The kinetics of mRNA transforming growth factor beta1 expression and its serum concentration in graft-versus-host disease after allogeneic hemopoietic stem cell transplantation for myeloid leukemias

Medical Science Monitor

Volumn 17, Issue 6, 2011, Pages

  Kyrcz Krzemień, Sławomira ^a   Helbig, Grzegorz ^a   Zielińska, Patrycja ^a   Markiewicz, Mirosław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Graft versus host disease; Myeloid leukemia; Transforming growth factor beta1

Indexed keywords

ACICLOVIR; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; MESSENGER RNA; METHOTREXATE; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYELOID LEUKEMIA; PNEUMOCYSTOSIS; PROTEIN EXPRESSION;

EID: 79958700672     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881804     Document Type: Article

References (31)

1. Fortunel NO, Hatzfeld A, Hatzfeld JA: Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood, 2000; 15(96): 2022-36
2. Blobe GC, Schiemann WP, Lodish HF: Role of TGF-β in human disorders. N Eng J Med, 2000; 342(18): 1350-58
3. Elliott RL, Blobe GC: Role of transforming growth factor beta in human cancer. J Clin Oncol, 2005; 23(9): 2078-93
4. Dong M, Blobe GC: Role of transforming growth factor beta in hematologic malignancies. Blood, 2006; 107(12): 4589-60
5. Border WA, Noble NA: TGF-β in tissue fibrosis. N Engl J Med, 1994; 331: 1286-92
6. Hirayama Y, Sakamaki S, Matsunaga A et al: Granulocyte-colony stimulating factor enhances the expression of transforming growth factorbeta mRNA in CD4-positive peripheral blood lymphocytes in the donors for allogeneic peripheral blood stem cell transplantation. Am J Hematol, 2002; 69(2): 138-40
7. Banovic T, MacDonald KP, Morris ES et al: TGFbeta in allogeneic stem cell transplantation: Friend or Foe? Blood, 2005; 106(6): 2206-14
8. Przepiorka D, Weisdorf D, Martin P et al: Consensus conference on acute GVHD grading. Bone Marrow Transplant, 1995; 15: 825-28
9. th Edition. Williams&Wilkins, 2004.
10. Giebel S, Lech-Marańda E, Czerw T et al: Analiza statystyczna w transplantacji komórek hematopoetycznych. Rekomendacje Polskiej Grupy ds. Leczenia Białaczek u Dorosłych. Cześć I-III. Acta Haemat Pol, 2005; 36(4): 409-28 [in Polish]
11. Hutchinson IV: The role of TGF-β in transplant rejection Transplant Proc, 1999; 31(Suppl.7A): 9S-13S
12. Martyre MC, Romquin N, Le Bousse-Kerdiles MC: Transforming growth factor and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol, 1994; 88: 9-16
13. Marek A, Brodzicki J, Liberek A, Korzon M: TGF-β (transforming growth factor-beta) in chronic inflammatory conditions - a new diagnostic and prognostic marker? Med Sci Monit, 2002; 8(7): RA145-51
14. El-Gamel A, Awad MR, Hasleton PS: Transforming growth factor-beta (TGF-β1) genotype and lung allograft fibrosis. J Heart Lung Transplant, 1999; 18: 517-23
15. Castilla A, Pieto J, Fausto N: Transforming growth factors (beta1) and (alpha) in chronic liver disease: effects of interferon therapy. N Engl J Med, 1991; 324: 933-40
16. Marek B, Kajdaniuk D, Mazurek U et al: Ocena ilościowa mRNA TGF-β1 w bioptacie wa{ogonek}troby w powia{ogonek}zaniu ze średniodobowym ste{ogonek}żeniem TGF-β1 w surowicy u chorych z przewlekłym zapaleniem wa{ogonek}troby typu B. Polish Archives of Internal Medicine, 2005; CXIV: 2(8): 738-45 [in Polish]
17. Murphy WJ, Longo DL: The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation. Immunol Rev, 1997; 157(1): 167-76
18. Storek J, Gooley T, Siadak M et al: Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graftversus- host disease. Blood, 1997; 90(12): 4705-9
19. Schmitz N, Beksac M, Bacigalupo A et al: Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. Haematologica, 2005; 90(5): 643-48
20. Rutella S, Pierelli L, Bonanno G et al: Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood, 2002; 100: 2562-71
21. Liem LM, Fibbe WE, van Houwelingen HC, Goulmy E: Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation, 1999; 67(1): 59-65
22. Visentainer JE, Lieber SR, Persoli LB et al: Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation. Exp Hematol, 2003; 31(11): 1044-50
23. Imamura M, Tanaka J, Hashino S et al: Immunopathogenesis of GVHD. Transplant Proc, 1996; 28: 1181-83
24. McCormick LL, Zhang Y, Tootell E, Gilliam AC: Anti-TGF-β treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versushost disease: a model for human scleroderma. J Immunol, 1999; 163; 5693-99
25. Zhang Y, McCormick LL, Desai SR et al: Murine sclerodermatous graftversus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol, 2002; 168(6): 3088-98
26. Ruzek MC, Sharda Jha S, Ledbetter S et al: A modified model of graftversus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. Arthritis Rheumatism, 2004; 50(4): 1319-31
27. Zhang Y, McCormick LL, Gilliam AC: Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol, 2003; 121(4): 713-19
28. Ochs LA, Blazar BR, Roy J et al: Cytokine expression in human cutaneous graft-versus-host disease. Bone Marrow Transplant, 1996; 17: 1085-92
29. Wu JM, Thoburn CJ, Wisell J et al: CD20, AIF-1, and TGF-β in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies. Modern Pathology, 2010; 23: 720-28
30. Li Q, Zhai Z, Xu X et al: Decrease of CD4(+)CD25(+) regulatory T cells and TGF-βeta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Leuk Res, 2010; 34(9): 1158-68
31. Martin PJ: Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med, 2008; 57(4): 177-83